National Medical Care Past Earnings Performance
Past criteria checks 2/6
National Medical Care has been growing earnings at an average annual rate of 28.1%, while the Healthcare industry saw earnings growing at 18.8% annually. Revenues have been growing at an average rate of 10.5% per year. National Medical Care's return on equity is 17.8%, and it has net margins of 22.5%.
Key information
28.1%
Earnings growth rate
28.1%
EPS growth rate
Healthcare Industry Growth | 12.3% |
Revenue growth rate | 10.5% |
Return on equity | 17.8% |
Net Margin | 22.5% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
National Medical Care's (TADAWUL:4005) Solid Earnings May Rest On Weak Foundations
Oct 29We Think National Medical Care's (TADAWUL:4005) Robust Earnings Are Conservative
Mar 14Recent updates
National Medical Care (TADAWUL:4005) Might Have The Makings Of A Multi-Bagger
Jan 30If EPS Growth Is Important To You, National Medical Care (TADAWUL:4005) Presents An Opportunity
Jan 08What National Medical Care Company's (TADAWUL:4005) P/E Is Not Telling You
Dec 12National Medical Care's (TADAWUL:4005) Solid Earnings May Rest On Weak Foundations
Oct 29National Medical Care (TADAWUL:4005) Shareholders Will Want The ROCE Trajectory To Continue
Sep 25Analysts Are Updating Their National Medical Care Company (TADAWUL:4005) Estimates After Its Second-Quarter Results
Aug 06Getting In Cheap On National Medical Care Company (TADAWUL:4005) Is Unlikely
Jul 26National Medical Care Company's (TADAWUL:4005) Shares May Have Run Too Fast Too Soon
Apr 05We Think National Medical Care's (TADAWUL:4005) Robust Earnings Are Conservative
Mar 14National Medical Care (TADAWUL:4005) Is Very Good At Capital Allocation
Mar 13Some Confidence Is Lacking In National Medical Care Company's (TADAWUL:4005) P/E
Dec 27Returns On Capital Are Showing Encouraging Signs At National Medical Care (TADAWUL:4005)
Dec 05We Like These Underlying Return On Capital Trends At National Medical Care (TADAWUL:4005)
Aug 07Is National Medical Care Company (TADAWUL:4005) Worth ر.س107 Based On Its Intrinsic Value?
May 29Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist
May 08Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist
Dec 19A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)
Oct 19National Medical Care (TADAWUL:4005) Is Doing The Right Things To Multiply Its Share Price
Aug 15National Medical Care's (TADAWUL:4005) Returns On Capital Are Heading Higher
May 13Earnings Update: National Medical Care Company (TADAWUL:4005) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Mar 03A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)
Feb 10Returns At National Medical Care (TADAWUL:4005) Appear To Be Weighed Down
Nov 10Returns On Capital At National Medical Care (TADAWUL:4005) Have Hit The Brakes
Jul 02Estimating The Intrinsic Value Of National Medical Care Company (TADAWUL:4005)
Apr 14Is National Medical Care Company (TADAWUL:4005) A Risky Dividend Stock?
Mar 25Will National Medical Care (TADAWUL:4005) Multiply In Value Going Forward?
Feb 23Update: National Medical Care (TADAWUL:4005) Stock Gained 25% In The Last Five Years
Feb 09National Medical Care Company's (TADAWUL:4005) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?
Jan 27Calculating The Fair Value Of National Medical Care Company (TADAWUL:4005)
Jan 14Is National Medical Care Company's (TADAWUL:4005) 3.8% Dividend Sustainable?
Dec 25Does National Medical Care's (TADAWUL:4005) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 10What Kind Of Shareholders Hold The Majority In National Medical Care Company's (TADAWUL:4005) Shares?
Nov 24Revenue & Expenses Breakdown
How National Medical Care makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 1,221 | 274 | 174 | 0 |
30 Jun 24 | 1,171 | 288 | 150 | 0 |
31 Mar 24 | 1,119 | 266 | 132 | 0 |
31 Dec 23 | 1,082 | 241 | 124 | 0 |
30 Sep 23 | 1,034 | 233 | 94 | 0 |
30 Jun 23 | 997 | 202 | 110 | 0 |
31 Mar 23 | 968 | 196 | 103 | 0 |
31 Dec 22 | 918 | 170 | 98 | 0 |
30 Sep 22 | 882 | 151 | 104 | 0 |
30 Jun 22 | 857 | 142 | 94 | 0 |
31 Mar 22 | 843 | 131 | 93 | 0 |
31 Dec 21 | 845 | 136 | 88 | 0 |
30 Sep 21 | 844 | 122 | 99 | 0 |
30 Jun 21 | 845 | 105 | 104 | 0 |
31 Mar 21 | 828 | 100 | 113 | 0 |
31 Dec 20 | 809 | 97 | 107 | 0 |
30 Sep 20 | 780 | 95 | 86 | 0 |
30 Jun 20 | 740 | 95 | 78 | 0 |
31 Mar 20 | 724 | 83 | 72 | 0 |
31 Dec 19 | 708 | 80 | 73 | 0 |
30 Sep 19 | 705 | 65 | 73 | 0 |
30 Jun 19 | 707 | 60 | 72 | 0 |
31 Mar 19 | 737 | 67 | 76 | 0 |
31 Dec 18 | 764 | 62 | 81 | 0 |
30 Sep 18 | 810 | 81 | 92 | 0 |
30 Jun 18 | 842 | 96 | 92 | 0 |
31 Mar 18 | 859 | 95 | 96 | 0 |
31 Dec 17 | 855 | 85 | 100 | 0 |
30 Sep 17 | 817 | -8 | 125 | 0 |
30 Jun 17 | 806 | -7 | 126 | 0 |
31 Mar 17 | 849 | 33 | 119 | 0 |
31 Dec 16 | 901 | 50 | 124 | 0 |
30 Sep 16 | 931 | 155 | 90 | 0 |
30 Jun 16 | 945 | 153 | 91 | 0 |
31 Mar 16 | 913 | 136 | 95 | 0 |
31 Dec 15 | 879 | 131 | 87 | 0 |
30 Sep 15 | 853 | 106 | 96 | 0 |
30 Jun 15 | 820 | 102 | 94 | 0 |
31 Mar 15 | 772 | 91 | 94 | 0 |
31 Dec 14 | 734 | 95 | 81 | 0 |
30 Sep 14 | 703 | 106 | 70 | 0 |
30 Jun 14 | 660 | 103 | 58 | 0 |
31 Mar 14 | 623 | 94 | 42 | 0 |
Quality Earnings: 4005 has a high level of non-cash earnings.
Growing Profit Margin: 4005's current net profit margins (22.5%) are lower than last year (22.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4005's earnings have grown significantly by 28.1% per year over the past 5 years.
Accelerating Growth: 4005's earnings growth over the past year (17.8%) is below its 5-year average (28.1% per year).
Earnings vs Industry: 4005 earnings growth over the past year (17.8%) exceeded the Healthcare industry 13.5%.
Return on Equity
High ROE: 4005's Return on Equity (17.8%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/06 17:29 |
End of Day Share Price | 2025/02/06 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
National Medical Care Company is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Ibrahim Elaiwat | Aljazira Capital Company |
Jassim Al-Jubran | Aljazira Capital Company |
Madhu Appissa | Al Rajhi Capital |